Study (year) | Clearly stated aim | Inclusion of consecutive patients | Prospective collection of data | Endpoints appropriate to the aim of the study | Unbiased assessment of the study endpoint | Follow-up period appropriate to the aim of the study | Loss to follow up less than 5% | Prospective calculation of the study size | An adequate control group | Contemporary groups | Baseline equivalence of groups | Adequate statistical analysis | TOTAL |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Feng et al. (2019) [18] | 2 | 2 | 2 | 2 | 1 | 1 | 2 | 0 | n/a | n/a | n/a | n/a | 12/16 |
Qiao et al. (2019) [19] | 2 | 0 | 1 | 2 | 1 | 2 | 2 | 0 | n/a | n/a | n/a | n/a | 10/16 |
Toyama et al. (2018) [20] | 2 | 2 | 2 | 2 | 1 | 1 | 2 | 0 | n/a | n/a | n/a | n/a | 12/16 |
Nishimura et al. (2018) [21] | 2 | 1 | 2 | 1 | 1 | 1 | 2 | 0 | n/a | n/a | n/a | n/a | 10/16 |
Kurozumi et al. (20187) [22] | 1 | 2 | 1 | 2 | 1 | 1 | 2 | 0 | n/a | n/a | n/a | n/a | 10/16 |
Luo et al. (2015) [23] | 2 | 2 | 1 | 1 | 1 | 2 | 1 | 0 | n/a | n/a | n/a | n/a | 10/16 |
Kamio et al. (2014) [7] | 2 | 2 | 2 | 1 | 0 | 2 | 2 | 0 | n/a | n/a | n/a | n/a | 11/16 |
Houlden et al. (2014) [9] | 1 | 0 | 2 | 1 | 2 | 1 | 2 | 0 | n/a | n/a | n/a | n/a | 9/16 |
Chung et al. (2012) [24] | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 0 | n/a | n/a | n/a | n/a | 13/16 |
Sasaki et al. (2010) [6] | 2 | 0 | 2 | 1 | 0 | 2 | 2 | 0 | n/a | n/a | n/a | n/a | 9/16 |
Chacko et al. (1996) [25] | 2 | 0 | 2 | 2 | 0 | 0 | 2 | 0 | 2 | 2 | 2 | 2 | 16/24 |